Analyzing DSAM Partners' Q2 and Q3 2021 Stock Holdings: Winners, Losers, and Emerging Trends

DSAM Partners, a London-based investment management firm, recently released its 13F filings, detailing its stock holdings for Q2 and Q3 of 2021. These regular reports offer investors a glimpse into the decisions made by institutional investors and any noticeable changes in their holdings. In this article, we will take a closer look at DSAM Partners' Q2 and Q3 2021 13F filings, identify the winners and losers, and explore emerging trends in the firm's investment strategy.

Winners and Losers

One of DSAM Partners' notable moves in Q3 were reducing its position in GFL Environmental (GFL.TO) by 34.9%, selling 552,000 shares and shaving the value of its position from $39,964,000 to $26,005,000. Similarly, Microsoft Corp (MSFT) and Alphabet Inc (GOOG) saw reductions in DSAM's holdings by 52.4% and 50%, respectively.

On the other hand, Lucid Group (LCID), an electric vehicle maker, saw the biggest increase in DSAM's portfolio, with the company purchasing 551,100 stocks in Q3, helping to establish a position worth $13,987,000. The also got behind Antero Resources (AR), Carrier Global Corp (CARR), and Volta Inc (VLTA), increasing positions by 54.6%, 36.3%, and 675,900 shares, respectively.

DSAM Partners also decreased its stakes in XPO Logistics Inc (XPO) by 69.1%, Stem Inc (STEM) by 72.1%, and Vontier Corporation (VNT) by 76.4%. Occidental Petroleum Corporation (OXY) saw the most significant decrease in the Q3 portfolio, with DSAM Partners selling 870,600 shares.

Emerging Trends

One of the interesting trends to emerge from DSAM Partners' Q2 and Q3 2021 13F filings is their increasing investment in electric vehicles and renewable energy companies. With the purchase of 551,100 shares of Lucid Group in Q3, DSAM Partners now holds a position worth almost $14 million in the EV maker. The firm also established a position in Volta Inc, a leading charging infrastructure provider for electric vehicles. DSAM Partners held 675,900 shares of Volta Inc worth $5,847,000 at the end of Q3, making it one of the company's top holdings.

Another emerging trend is their interest in the biotech sector. DSAM Partners reduced its position in Immatics N.V (IMTX) by 100% but established new positions in Bridgene BioPharma Inc (BBIO) and Krystal Biotech Inc (KRYS) worth approximately $4.9 million and $4.7 million, respectively. They also invested almost $4.6 million in an acquisition SPAC DMY Technology Group Inc III (DMYI).

Final Thoughts

DSAM Partners' Q2 and Q3 2021 13F filings present a clear picture of an ever-changing investment portfolio. While the firm's reduction in Microsoft and Alphabet is notable, its move into the EV and biotech sectors demonstrates confidence in those sectors' ability to deliver attractive returns. Overall, DSAM Partners' latest filings show that it is positioning itself for the future while also staying committed to its existing investments.